How far away from having an effective treatment option for progressive multiple sclerosis are we?

Expert Opin Pharmacother. 2017 Jul;18(10):953-955. doi: 10.1080/14656566.2017.1326909. Epub 2017 May 16.

Authors

Arianna Sartori¹, Jacopo Fantini¹, Paolo Manganotti¹

Affiliation

¹ a Department of Medical, Surgical, and Health Sciences , University of Trieste, Azienda Sanitaria Universitaria Integrata di Trieste, Neurology Unit - Cattinara Hospital , Trieste , Italy.

PMID: 28480777
DOI: 10.1080/14656566.2017.1326909

No abstract available

Keywords: Clinical trials; multiple sclerosis; primary progressive; progression; secondary progressive.